Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BALCHEM CORP Board/Management Information 2013

Jun 5, 2013

31041_rns_2013-06-05_b088bef0-405d-47e6-be80-47d709d5467f.zip

Board/Management Information

Open in viewer

Opens in your device viewer

8-K 1 fom8k.htm BALCHEM CORPORATION 8-K 5-30-2013 Licensed to: Thomson Reuters Accelus Document created using Disclosure Solutions PROFILE 2.2.0.0 Copyright 1995 - 2013 Thomson Reuters Accelus. All rights reserved.

UNITED STATES

Anchor SECURITIES AND EXCHANGE COMMISSION

Anchor Washington, D.C. 20549

Anchor FORM 8-K

Anchor Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (date of earliest event reported): May 30, 2013

Anchor Balchem Corporation

Anchor (Exact name of registrant as specified in its charter)

Maryland 1-13648 13-257-8432
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

Anchor 52 Sunrise Park Road, New Hampton, NY 10958

Anchor (Address of principal executive offices) (Zip Code)

Anchor

Registrant’s telephone number, including area code: (845) 326-5600

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Dana E. Putnam, Ph.D., Vice President and General Manager, Animal Nutrition and Health, notified Balchem Corporation (the “Company”) of his resignation from the Company, effective June 30, 2013 to pursue other endeavors. The Company thanks Dr. Putnam for his services.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

By:/s/ Dino A. Rossi
Dino A. Rossi, President &
Chief Executive Officer
Dated: June 5, 2013